Benzinga | Jul 29, 2021 04:37PM EDT

Veracyte Q2 EPS $(0.13) Beats $(0.25) Estimate, Sales $55.10M Beat $48.06M Estimate

Veracyte (NASDAQ:VCYT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.25) by 48 percent. This is a 40.91 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $55.10 million which beat the analyst consensus estimate of $48.06 million by 14.65 percent. This is a 166.13 percent increase over sales of $20.70 million the same period last year.